Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000097:blood / Q000188:drug therapy; D002849:Chromatography, Gas; D002986:Clinical Trials as Topic; D004048:Diethylamines / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D007192:Indenes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007189:Indans; D007192:Indenes